SCHEMBL21532274

SCHEMBL21532274

c1ccc(-c2nnc(-c3ccccc3)n2-c2cccc3c2c2ccccc2n3-c2ccccc2-n2c3ccccc3c3c4oc5ccccc5c4ccc32)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.35
HIF1A Q16665 1/20 0.35
AKT1 P31749 2/20 0.33
MAPT P10636 2/20 0.32
MEN1 O00255 1/20 0.32
CSF1R P07333 1/20 0.32
PDGFRB P09619 1/20 0.32
KIT P10721 1/20 0.32
FLT3 P36888 1/20 0.32
KMT2A Q03164 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
DRD4 P21917 1/20 0.31
KDM4E B2RXH2 1/20 0.31
RGS12 O14924 1/20 0.31
USP2 O75604 1/20 0.31
ALDH1A1 P00352 1/20 0.31
POLB P06746 1/20 0.31
ALOX15 P16050 1/20 0.31
APOBEC3A P31941 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21532481 0.95 AKT1 (0.36) SMN1; SMN2HIF1AAKT1
SCHEMBL21532800 0.94 AKT1 (0.36) SMN1; SMN2HIF1AAKT1
SCHEMBL21532660 0.93 SMN1; SMN2 (0.33) SMN1; SMN2HIF1AAKT1MAPTMEN1
SCHEMBL21532520 0.92 ALOX5 (0.36) SMN1; SMN2HIF1AAKT1MAPTKDM4E
SCHEMBL21532609 0.92 ALDH1A1 (0.34) SMN1; SMN2HIF1AAKT1MAPTMEN1
SCHEMBL21532424 0.91 SMN1; SMN2 (0.34) SMN1; SMN2HIF1AAKT1MAPTMEN1
SCHEMBL21532279 0.91 ALDH1A1 (0.34) SMN1; SMN2HIF1AAKT1MAPTMEN1
SCHEMBL21532303 0.90 ALDH1A1 (0.33) SMN1; SMN2HIF1AAKT1MAPTMEN1
SCHEMBL23911751 0.89 ALOX5 (0.34) SMN1; SMN2HIF1AAKT1MEN1KMT2A
SCHEMBL21532245 0.89 ALOX5 (0.34) SMN1; SMN2HIF1AAKT1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11145825-B2 Condensed cyclic compound and organic light-emitting device including i he same SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-10-12 US disclosed
US-20190334095-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-10-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11145825-B2 Condensed cyclic compound and organic light-emitting device including i he same CRY1, CCNT1, CCNA1 SMN1; SMN2 2430/4885HIF1A 657/4885AKT1 2105/4885
US-20190334095-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNT1, ARL1 SMN1; SMN2 2103/4885HIF1A 1000/4885AKT1 2483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.